Aardvark Therapeutics, Inc. Common Stock (AARD) — Financial Flexibility Index
Aardvark Therapeutics, Inc. Common Stock (AARD) has a Financial Flexibility Index of -1.71x as of September 2025. Free cash flow of $-18.51 Million (operating CF $-18.52 Million minus capex $4.00K) represents -2% of total liabilities ($10.85 Million). Check financial resilience of Aardvark Therapeutics, Inc. Common Stock to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aardvark Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Aardvark Therapeutics, Inc. Common Stock across 3 annual periods. See how liquid is Aardvark Therapeutics, Inc. Common Stock's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Aardvark Therapeutics, Inc. Common Stock (2022–2024)
Year-by-year free cash flow to debt coverage for Aardvark Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see Aardvark Therapeutics, Inc. Common Stock (AARD) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.14x | $-17.98 Million | $-18.09 Million | $132.15 Million | ▼ -5.9% |
| 2023 | -0.13x | $-5.82 Million | $-5.82 Million | $45.34 Million | ▲ +45.6% |
| 2022 | -0.24x | $-10.54 Million | $-10.54 Million | $44.68 Million | — |